{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:27:20Z","timestamp":1789752440122,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jacr.org","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jacr.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T09:07:57Z","timestamp":1556701677000},"page":"S300-S314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S","title":["ACR Appropriateness Criteria\u00ae Thyroid Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Jenny K.","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge D.","family":"Oldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Policeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judah","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bykowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Benjamin","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy F.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Moonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Pannell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathan M.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jamainternmed.2013.9245","article-title":"Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study","volume":"173","author":"Smith-Bindman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archsurg.2012.96","article-title":"Positional dyspnea and tracheal compression as indications for goiter resection","volume":"147","author":"Stang","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.jacr.2019.02.004_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2214\/AJR.13.10972","article-title":"Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system?","volume":"202","author":"Hobbs","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.surg.2013.07.006","article-title":"Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States","volume":"154","author":"Sosa","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jacr.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/ERC-10-0233","article-title":"Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?","volume":"18","author":"Deandreis","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jacr.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacr.2014.09.038","article-title":"Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee","volume":"12","author":"Hoang","year":"2015","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.jacr.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee","volume":"14","author":"Tessler","year":"2017","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.jacr.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2019.02.004_bib10","author":"American College of Radiology"},{"key":"10.1016\/j.jacr.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1089\/thy.2013.0238","article-title":"The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment","volume":"24","author":"Sohn","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1089\/thy.2012.0099","article-title":"One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy","volume":"22","author":"Padovani","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinternmed.2011.677","article-title":"Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism","volume":"172","author":"Rhee","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib14","author":"American College of Radiology"},{"key":"10.1016\/j.jacr.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2017.0562","article-title":"Screening for thyroid cancer: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Lin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association\u00a0Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/thy.2013.0291","article-title":"American Thyroid Association statement on optimal surgical management of goiter","volume":"24","author":"Chen","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2214\/ajr.117.1.195","article-title":"A\u00a0comparison of technetium 99M and iodine 123 for thyroid imaging","volume":"117","author":"Atkins","year":"1973","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib20","first-page":"e1","article-title":"TSI assay utilization: impact on costs of Graves\u2019 hyperthyroidism diagnosis","volume":"18","author":"McKee","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jacr.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/thy.2006.0104","article-title":"Color flow Doppler sonography for the etiologic diagnosis of hyperthyroidism","volume":"17","author":"Erdogan","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2265.2007.02832.x","article-title":"Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves\u2019 disease","volume":"67","author":"Ota","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacr.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/thy.2005.15.1249","article-title":"Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis","volume":"15","author":"Kurita","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4158\/EP11170.RA","article-title":"Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool","volume":"18","author":"Alzahrani","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacr.2019.02.004_bib25","first-page":"363","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"93","author":"Kravets","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jacr.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/RLU.0b013e3182175477","article-title":"Subclinical hyperthyroidism: current concepts and scintigraphic imaging","volume":"36","author":"Intenzo","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid\u00a0nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0039-6060(03)00424-0","article-title":"Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer","volume":"134","author":"Kouvaraki","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jacr.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2214\/AJR.09.2386","article-title":"Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT","volume":"193","author":"Choi","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/thy.2007.0269","article-title":"Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography","volume":"18","author":"Kim","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1503\/cjs.011015","article-title":"The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer","volume":"59","author":"Kocharyan","year":"2016","journal-title":"Can J Surg"},{"key":"10.1016\/j.jacr.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejso.2012.07.119","article-title":"Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma","volume":"39","author":"Lee","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jacr.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hed.23277","article-title":"Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients","volume":"36","author":"Lesnik","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.jacr.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/thy.2014.0096","article-title":"American Thyroid Association statement on preoperative imaging for thyroid cancer surgery","volume":"25","author":"Yeh","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2265.2006.02612.x","article-title":"Integrated 18F-FDG PET\/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT","volume":"65","author":"Jeong","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacr.2019.02.004_bib36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jc.2008-1747","article-title":"Assessment of the\u00a0incremental value of recombinant thyrotropin stimulation before\u00a02-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography imaging to localize residual differentiated thyroid cancer","volume":"94","author":"Leboulleux","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib37","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2015-4290","article-title":"Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine","volume":"101","author":"Momesso","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s002590050223","article-title":"Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma","volume":"25","author":"Leger","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2967\/jnumed.107.040311","article-title":"Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma","volume":"48","author":"Silberstein","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/RLU.0b013e31823ea463","article-title":"Diagnostic value of recombinant human thyrotropin-stimulated (1)(2)(3)I whole-body scintigraphy in the follow-up of patients with differentiated thyroid cancer","volume":"37","author":"Alzahrani","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003072-200101000-00002","article-title":"Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer","volume":"26","author":"Mandel","year":"2001","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/thy.2000.10.573","article-title":"Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?","volume":"10","author":"Fatourechi","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib43","first-page":"629","article-title":"Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma","volume":"78","author":"Sherman","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003072-200412000-00005","article-title":"Post I-131 therapy\u00a0scanning in patients with thyroid carcinoma metastases: an unnecessary cost or a relevant contribution?","volume":"29","author":"Souza Rosario","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2011-2512","article-title":"Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients","volume":"97","author":"Schvartz","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"Tuttle","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2265.2011.04002.x","article-title":"Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer","volume":"75","author":"Vaisman","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacr.2019.02.004_bib48","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00268-008-9588-7","article-title":"Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer","volume":"32","author":"Ahn","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.jacr.2019.02.004_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/RLU.0b013e318203bb6c","article-title":"The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas","volume":"36","author":"Yoshio","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1477-7819-10-192","article-title":"Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management","volume":"10","author":"Schreinemakers","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jacr.2019.02.004_bib51","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6600930","article-title":"Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging","volume":"88","author":"Pellegriti","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jacr.2019.02.004_bib52","first-page":"6647","article-title":"Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET","volume":"34","author":"Sesti","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jacr.2019.02.004_bib53","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1210\/jc.2007-1211","article-title":"Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels","volume":"92","author":"Giraudet","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jacr.2019.02.004_bib55","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00384-016-2664-9","article-title":"Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis","volume":"31","author":"Vreugdenburg","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jacr.2019.02.004_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-22542-5_4","article-title":"Medullary thyroid carcinoma: imaging","volume":"204","author":"Delorme","year":"2015","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.jacr.2019.02.004_bib57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2004-1500","article-title":"High frequency of bone\/bone marrow involvement in advanced medullary thyroid cancer","volume":"90","author":"Mirallie","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacr.2019.02.004_bib58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12020-012-9671-6","article-title":"Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis","volume":"42","author":"Treglia","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jacr.2019.02.004_bib59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2967\/jnumed.107.047720","article-title":"18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation","volume":"49","author":"Koopmans","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","article-title":"Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"48","author":"Ong","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib61","first-page":"66","article-title":"18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma","volume":"43","author":"Szakall","year":"2002","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib62","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ejso.2007.08.005","article-title":"The role of 18F-FDG PET\/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study","volume":"34","author":"Rubello","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jacr.2019.02.004_bib63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00330-008-1280-7","article-title":"The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT","volume":"19","author":"Beheshti","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2019.02.004_bib64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00259-011-2031-6","article-title":"Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET\/CT in patients with recurrent medullary thyroid carcinoma","volume":"39","author":"Treglia","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2019.02.004_bib65","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2967\/jnumed.112.105940","article-title":"Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma","volume":"53","author":"Verbeek","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib66","first-page":"912","article-title":"Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma","volume":"37","author":"Baudin","year":"1996","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacr.2019.02.004_bib67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNM.0000000000000240","article-title":"Comparison of (6)(8)Ga-DOTATATE PET-CT, (1)(8)F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma","volume":"36","author":"Ozkan","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacr.2019.02.004_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00259-009-1204-z","article-title":"Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET\/CT in the detection of recurrent medullary thyroid carcinoma","volume":"37","author":"Conry","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2019.02.004_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00259-017-3701-9","article-title":"68)Ga-DOTATATE PET\/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with (111)In-octreotide SPECT\/CT and conventional imaging","volume":"44","author":"Yamaga","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2019.02.004_bib70","author":"American College of Radiology"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144019301449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144019301449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T09:18:26Z","timestamp":1556702306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144019301449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1546144019301449"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2019.02.004","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Thyroid Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Radiology","name":"copyright","label":"Copyright"}]}}